is farxiga a glp 1 agonist Glucagon-like peptide receptor agonists: cardiovascular benefits and mechanisms of action New GLP-1 Guidelines for Type

Effects of glucagon-like peptide-1 receptor agonists on gut microbiota in dehydroepiandrosterone-induced polycystic ovary syndrome mice: compared evaluation of liraglutide and semaglutide intervention

doi: 10.1097/JIM.0000000000000129 156 KingMRAndersonNJDeciuMGuernseyLSCundiffMHajizadehSet al

And of course, the weight loss

Glucose-lowering drugs or strategies, atherosclerotic cardiovascular events, and heart failure in people with or at risk of type 2 diabetes: an updated systematic review and meta-analysis of randomised cardiovascular outcome trials

However, the results were presented to both the expert panel and in the manuscript according to study design, outcome measurement, and the quality of outcome reporting

However, nausea was more prevalent than in the control group [228]